SUPPRESSION OF DRUG-METABOLIZING ENZYMES AND EFFLUX TRANSPORTERS IN THE INTESTINE OF ENDOTOXIN-TREATED RATS
- 1 January 2004
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 32 (1) , 20-27
- https://doi.org/10.1124/dmd.32.1.20
Abstract
Infection and inflammation impose a suppression in the expression and activity of several drug transporters and drug-metabolizing enzymes in liver. In the intestine, cytochrome P450 3A (CYP3A), P-glycoprotein (PGP/mdr1), and the multidrug resistance-associated protein 2 (MRP2) are important barriers to the absorption of many clinically important drugs; thus, the expression and activity of these proteins were examined in inflammation. Transport and metabolism were determined in jejunum segments isolated at 24 h from endotoxin-treated or control rats (n = 8) mounted in Ussing chambers. Transport and metabolism of 3H-digoxin, 5-carboxyfluorescein (5-CF), amiodarone (AM), and 7-benzyloxyquinoline (7-BQ) were measured for 90 min in the presence and absence of inhibitors. Reverse transcription-polymerase chain reaction was used to measure mRNA levels. As compared with controls, levels of mdr1a and mrp2 mRNA were significantly decreased by approximately 50% in the jejunum of LPS-treated rats. Corresponding reductions in the basolateral→apical efflux of digoxin, AM, and 5-CF were observed, resulting in significant increases in the apical→basolateral absorption of these compounds. Intestinal CYP3A mRNA levels and CYP3A-mediated metabolism of 7-BQ and AM were also decreased by approximately 50 to 70% (p < 0.05) in the LPS group. Mannitol permeability and lactate dehydrogenase release were not altered. These studies indicate that endotoxin-induced inflammation imposes a reduction in the intestinal expression and activity of PGP, mrp2, and CYP3A in rats, which elicits corresponding changes in the intestinal transport and metabolism of their substrates. Hence, infection and inflammatory diseases may impose variability in drug bioavailability through alterations in the intestinal expression and activity of drug transporters and metabolic enzymes.This publication has 38 references indexed in Scilit:
- Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxinBritish Journal of Pharmacology, 2003
- Tissue Distribution and Chemical Induction of Multiple Drug Resistance Genes in RatsDrug Metabolism and Disposition, 2002
- Inflammatory Cytokines, but Not Bile Acids, Regulate Expression of Murine Hepatic Anion Transporters in EndotoxemiaThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane ReceptorJournal of Biological Chemistry, 2002
- Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3Pflügers Archiv - European Journal of Physiology, 2001
- Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transportEuropean Journal of Pharmaceutical Sciences, 2001
- Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in miceInternational Immunopharmacology, 2001
- Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by RifampinJournal of Biological Chemistry, 2001
- Human Cytochrome P450 EnzymesPublished by Springer Nature ,1995
- Liver Nonparenchymal Cells Are Stimulated to Provide Interleukin 6 for Induction of the Hepatic Acute-Phase Response in Endotoxemia but Not in Remote Localized InflammationArchives of Surgery, 1992